In contrast with a previous report suggesting that disease severity might be predicted by the β-SG expression level in patients with LGMD2E [11], we did not find any relationship between β-SG expression and disease severity in our patients with this subtype. This evidence concerns the gene BSG and autosomal recessive limb-girdle muscular dystrophy type 2E.